Bionano Genomics, Inc. BNGOW 深 滬
已收盤 08-17 16:00:00 美东时间
0.0036
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.0036
- 總市值 100.37万
- 52周最高 0.604
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.0019
- 委 比 0.00%
- 總股本 2.79亿
- 歷史最高 11.82
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.0019
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025
Bionano Genomics participated in the 2025 AMP Annual Meeting, showcasing Optical Genome Mapping (OGM) technology for enhanced structural variant (SV) detection._presentations highlighted OGM's utility across inherited diseases, reproductive disorders, hematological malignancies, and solid tumors. Thirteen studies demonstrated OGM's ability to detect novel and clinically relevant SVs, often complementing traditional methods. Researchers also prese...
12-11 13:00
Bionano Laboratories Gains 47% CMS Reimbursement Increase For OGM Blood-Cancer Test Code 81195 In 2026
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), announced today that the clinical
12-03 21:06
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $7
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $11 to $7.
11-24 20:45
Bionano jumps 6% on Q3 revenue beat, 2025 guidance range
Bionano Genomics (BNGO) is up ~6% in after-hours trading Thursday after reporting Q3 financial results that beat on revenue and reiterating full-year revenue guidance that includes the consensus. Full...
11-14 06:51
Bionano Genomics Affirms FY2025 Sales Guidance of $26.000M-$30.000M vs $28.136M Est
Bionano Genomics (NASDAQ:BNGO) affirms FY2025 sales outlook from $26.000 million-$30.000 million to $26.000 million-$30.000 million vs $28.136 million estimate.
11-14 06:16
Bionano Genomics Q3 Sales $7.367M Beat $6.871M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $7.367 million which beat the analyst consensus estimate of $6.871 million by 7.22 percent. This is a 21.31 percent increase over sales of $6.073 million the
11-14 05:02
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
Earnings week ahead: DIS, CSCO, OXY, PLUG, B, AMAT, JD, BYND, PSKY, and more
Earnings in the upcoming week will spotlight a diverse lineup across media, technology, energy, aerospace, and consumer sectors. The Walt Disney Company (DIS) and Paramount Skydance (PSKY) will be in ...
11-09 21:16
Bionano Genomics Publishes Study Demonstrating That Optical Genome Mapping Can Overcome Key Limitations Of Targeted RNA-Sequencing Panels In Detecting Therapeutically Relevant Gene Rearrangements In Acute Leukemia
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how optical genome mapping (OGM) can address key limitations of
11-06 21:28
Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025
Bionano Genomics将于2025年11月13日（星期四）下午4:30 ET举行电话会议和网络直播，报告第三季度2025的财务结果，并讨论公司近期进展。参与者可通过提供的链接注册并参与。网络直播将在投资者关系网站存档至少30天。联系人包括首席执行官Erik Holmlin和投资者关系代表Kelly Gura。
10-30 20:05
